life science investing Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference 20 April 2023
life science investing Eupraxia Pharmaceuticals Reports Fourth Quarter and 2022 Financial Results 23 March 2023
life science investing Eupraxia Pharmaceuticals Completes Patient Enrollment for its Phase 2 Trial in Knee Osteoarthritis 07 December 2022
